Patent · US Active

CRISPR enabled multiplexed genome engineering

US10266849B2 · kind B2 · utility

20Cited by
5References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 11, 2015
Grant dateApr 23, 2019
Priority date
Expiry dateMar 5, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2330/31
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Described herein are methods and vectors for rational, multiplexed manipulation of chromosomes within open reading frames (e.g., in protein libraries) or any segment of a chromosome in a cell or population of cells, in which various CRISPR systems are used.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.